Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case‐Control Study in Northern and Eastern China and Implications for Chemoprevention

BACKGROUND. Obesity is a consideration in the pharmacologic intervention for estrogen receptor (ER) positive (ER+) breast cancer risk. Body mass index (BMI) and waist/hip ratio (WHR) have demonstrated different effects on breast cancer risk in relation to estrogen receptor (ER) status, but the resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Liu, Liyuan, Cui, Shude, Tian, Fuguo, Fan, Zhimin, Geng, Cuizhi, Cao, Xuchen, Yang, Zhenlin, Wang, Xiang, Liang, Hong, Wang, Shu, Jiang, Hongchuan, Duan, Xuening, Wang, Haibo, Li, Guolou, Wang, Qitang, Zhang, Jianguo, Jin, Feng, Tang, Jinhai, Li, Liang, Zhu, Shiguang, Zuo, Wenshu, Ma, Zhongbing, Zhou, Fei, Yu, Lixiang, Xiang, Yujuan, Shen, Shuohao, Yu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728030/
https://www.ncbi.nlm.nih.gov/pubmed/28912152
http://dx.doi.org/10.1634/theoncologist.2017-0148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728030/
https://www.ncbi.nlm.nih.gov/pubmed/28912152
http://dx.doi.org/10.1634/theoncologist.2017-0148

Ejemplares similares